XPC Peptide
€100.00
In stock
SKU
350531
Protein Family: Enzymes
Pathway and Disease: Cancers, Replication and Repair
Alternate Names: DNA-repair protein complementing XP-C cells; Xeroderma pigmentosum group C-complementing protein; p125; XPC; XPCC
Accession No.: Q01831, NP_004619
Description:
Xeroderma pigmentosum group C-complementing protein (XPC) is involved in DNA excision repair by recognizing DNA damage and altering chromatin structure for damage-processing enzymes. Defects in XPC are a cause of xeroderma pigmentosum complementation group C characterized by solar sensitivity and skin cancer predisposition.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1756.7 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200169 is selected from a sequence within the C-term region of human XPC. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C65H105N21O34S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Cancers, Replication and Repair
Alternate Names: DNA-repair protein complementing XP-C cells; Xeroderma pigmentosum group C-complementing protein; p125; XPC; XPCC
Accession No.: Q01831, NP_004619
Description:
Xeroderma pigmentosum group C-complementing protein (XPC) is involved in DNA excision repair by recognizing DNA damage and altering chromatin structure for damage-processing enzymes. Defects in XPC are a cause of xeroderma pigmentosum complementation group C characterized by solar sensitivity and skin cancer predisposition.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1756.7 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200169 is selected from a sequence within the C-term region of human XPC. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C65H105N21O34S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review